US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 121.460
  • -1.360-1.11%
Close Jul 12 16:00 ET
  • 121.390
  • -0.070-0.06%
Post 19:59 ET
46.55BMarket Cap-7790P/E (TTM)

Moderna Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-90.91%167M
-64.22%6.75B
-45.37%2.81B
-44.50%1.79B
-93.08%316M
-69.06%1.84B
6.42%18.88B
-25.90%5.15B
-33.32%3.22B
8.33%4.57B
Operating revenue
-90.86%167M
-63.81%6.67B
-42.52%2.79B
-43.69%1.76B
-93.53%293M
-69.15%1.83B
4.30%18.44B
-29.46%4.86B
-35.39%3.12B
7.50%4.53B
Cost of revenue
-87.88%96M
-13.35%4.69B
-51.56%929M
103.73%2.24B
-47.07%731M
-22.12%792M
106.95%5.42B
101.47%1.92B
52.35%1.1B
84.13%1.38B
Gross profit
-93.21%71M
-84.69%2.06B
-41.69%1.88B
-121.42%-454M
-113.03%-415M
-78.75%1.05B
-10.98%13.46B
-46.12%3.23B
-48.38%2.12B
-8.08%3.19B
Operating expense
-5.31%1.34B
55.98%6.3B
13.75%1.88B
63.31%1.56B
96.75%1.45B
102.87%1.41B
121.56%4.04B
181.26%1.65B
73.77%954M
83.13%738M
Selling and administrative expenses
-10.16%274M
36.84%1.55B
25.33%470M
58.99%442M
57.35%332M
13.81%305M
99.65%1.13B
86.57%375M
65.48%278M
74.38%211M
Research and development costs
-6.01%1.06B
47.04%4.85B
16.10%1.41B
41.46%1.16B
61.69%1.15B
104.15%1.13B
65.49%3.3B
86.88%1.21B
57.39%820M
68.65%710M
Other operating expenses
----
75.77%-94M
-96.92%2M
69.44%-44M
84.70%-28M
80.95%-24M
47.21%-388M
124.81%65M
-2.86%-144M
-31.65%-183M
Operating profit
-245.90%-1.27B
-145.00%-4.24B
-99.62%6M
-272.56%-2.01B
-176.30%-1.87B
-108.66%-366M
-29.15%9.42B
-70.79%1.58B
-67.23%1.17B
-20.08%2.45B
Net non-operating interest income expense
14.00%114M
123.98%383M
25.97%97M
90.00%95M
160.00%91M
1,011.11%100M
850.00%171M
305.26%77M
50M
1,850.00%35M
Non-operating interest income
10.09%120M
110.50%421M
18.39%103M
81.03%105M
160.00%104M
626.67%109M
1,011.11%200M
1,142.86%87M
1,350.00%58M
1,233.33%40M
Non-operating interest expense
-33.33%6M
31.03%38M
-40.00%6M
25.00%10M
160.00%13M
50.00%9M
--29M
--10M
100.00%8M
0.00%5M
Other net income (expense)
66.67%-13M
-437.50%-86M
-1,550.00%-33M
-4,200.00%-41M
437.50%27M
-457.14%-39M
44.83%-16M
89.47%-2M
116.67%1M
-366.67%-8M
Gain on sale of security
57.14%-15M
-260.00%-72M
-1,000.00%-22M
-825.00%-37M
375.00%22M
-483.33%-35M
---20M
---2M
---4M
-500.00%-8M
Other non- operating income (expenses)
150.00%2M
-450.00%-14M
---11M
-180.00%-4M
--5M
-300.00%-4M
113.79%4M
--0
183.33%5M
----
Income before tax
-281.97%-1.17B
-141.17%-3.94B
-95.77%70M
-260.89%-1.96B
-170.70%-1.75B
-107.21%-305M
-27.93%9.58B
-69.41%1.66B
-65.74%1.22B
-19.23%2.47B
Income tax
102.60%10M
-36.36%772M
-177.37%-147M
860.92%1.67B
-233.21%-369M
-167.13%-384M
12.00%1.21B
-64.94%190M
-20.55%174M
-2.12%277M
Net income
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
Net income continuous Operations
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
Minority interest income
Net income attributable to the parent company
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
Basic earnings per share
-1,635.00%-3.07
-158.00%-12.33
-85.04%0.57
-456.93%-9.53
-165.23%-3.62
-97.80%0.2
-29.86%21.26
-68.33%3.81
-67.71%2.67
-19.91%5.55
Diluted earnings per share
-1,715.79%-3.07
-161.28%-12.33
-84.76%0.55
-476.68%-9.53
-169.08%-3.62
-97.79%0.19
-28.88%20.12
-68.02%3.61
-67.14%2.53
-18.89%5.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -90.91%167M-64.22%6.75B-45.37%2.81B-44.50%1.79B-93.08%316M-69.06%1.84B6.42%18.88B-25.90%5.15B-33.32%3.22B8.33%4.57B
Operating revenue -90.86%167M-63.81%6.67B-42.52%2.79B-43.69%1.76B-93.53%293M-69.15%1.83B4.30%18.44B-29.46%4.86B-35.39%3.12B7.50%4.53B
Cost of revenue -87.88%96M-13.35%4.69B-51.56%929M103.73%2.24B-47.07%731M-22.12%792M106.95%5.42B101.47%1.92B52.35%1.1B84.13%1.38B
Gross profit -93.21%71M-84.69%2.06B-41.69%1.88B-121.42%-454M-113.03%-415M-78.75%1.05B-10.98%13.46B-46.12%3.23B-48.38%2.12B-8.08%3.19B
Operating expense -5.31%1.34B55.98%6.3B13.75%1.88B63.31%1.56B96.75%1.45B102.87%1.41B121.56%4.04B181.26%1.65B73.77%954M83.13%738M
Selling and administrative expenses -10.16%274M36.84%1.55B25.33%470M58.99%442M57.35%332M13.81%305M99.65%1.13B86.57%375M65.48%278M74.38%211M
Research and development costs -6.01%1.06B47.04%4.85B16.10%1.41B41.46%1.16B61.69%1.15B104.15%1.13B65.49%3.3B86.88%1.21B57.39%820M68.65%710M
Other operating expenses ----75.77%-94M-96.92%2M69.44%-44M84.70%-28M80.95%-24M47.21%-388M124.81%65M-2.86%-144M-31.65%-183M
Operating profit -245.90%-1.27B-145.00%-4.24B-99.62%6M-272.56%-2.01B-176.30%-1.87B-108.66%-366M-29.15%9.42B-70.79%1.58B-67.23%1.17B-20.08%2.45B
Net non-operating interest income expense 14.00%114M123.98%383M25.97%97M90.00%95M160.00%91M1,011.11%100M850.00%171M305.26%77M50M1,850.00%35M
Non-operating interest income 10.09%120M110.50%421M18.39%103M81.03%105M160.00%104M626.67%109M1,011.11%200M1,142.86%87M1,350.00%58M1,233.33%40M
Non-operating interest expense -33.33%6M31.03%38M-40.00%6M25.00%10M160.00%13M50.00%9M--29M--10M100.00%8M0.00%5M
Other net income (expense) 66.67%-13M-437.50%-86M-1,550.00%-33M-4,200.00%-41M437.50%27M-457.14%-39M44.83%-16M89.47%-2M116.67%1M-366.67%-8M
Gain on sale of security 57.14%-15M-260.00%-72M-1,000.00%-22M-825.00%-37M375.00%22M-483.33%-35M---20M---2M---4M-500.00%-8M
Other non- operating income (expenses) 150.00%2M-450.00%-14M---11M-180.00%-4M--5M-300.00%-4M113.79%4M--0183.33%5M----
Income before tax -281.97%-1.17B-141.17%-3.94B-95.77%70M-260.89%-1.96B-170.70%-1.75B-107.21%-305M-27.93%9.58B-69.41%1.66B-65.74%1.22B-19.23%2.47B
Income tax 102.60%10M-36.36%772M-177.37%-147M860.92%1.67B-233.21%-369M-167.13%-384M12.00%1.21B-64.94%190M-20.55%174M-2.12%277M
Net income -1,587.34%-1.18B-156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B
Net income continuous Operations -1,587.34%-1.18B-156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B
Minority interest income
Net income attributable to the parent company -1,587.34%-1.18B-156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,587.34%-1.18B-156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B
Basic earnings per share -1,635.00%-3.07-158.00%-12.33-85.04%0.57-456.93%-9.53-165.23%-3.62-97.80%0.2-29.86%21.26-68.33%3.81-67.71%2.67-19.91%5.55
Diluted earnings per share -1,715.79%-3.07-161.28%-12.33-84.76%0.55-476.68%-9.53-169.08%-3.62-97.79%0.19-28.88%20.12-68.02%3.61-67.14%2.53-18.89%5.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg